Antibiotics


  • Quality Measures Need to be Field-Tested, Researchers Find
    ALEXANDRIA, Va. -- A group of researchers has developed a set of "quality indicators" to measure the quality of antibiotic use in hospitalized patients with lower respiratory tract infections (LRTIs) by combining scientific evidence with expert opinion, according to an ...More
    July 26, 2005 Posted in News
  • Hospira Ships First Orders of Ceftriaxone Injection
    LAKE FOREST, Ill. -- Hospira, Inc. announced today that it has shipped the first customer orders of the company's generic ceftriaxone for injection, USP. The medication is the generic version of Roche Pharmaceuticals' Rocephin, the world's leading injectable antibiotic, ...More
    July 20, 2005 Posted in News
  • Research Shows Topical Silver as an Effective Defense Against Growing MRSA Threat
    PORTLAND, Ore. -- AcryMed Inc., a medical device company specializing in wound care and infection control technology, today released research findings that show silver to be effective in combating methicillin-resistant Staphylococcus aureus (MRSA) topically, a potentially ...More
    July 12, 2005 Posted in News
  • Hospitals Cut Surgical Infection Rate by 27 Percent in One Year
    Fifty-six hospitals from 50 states and U.S. territories, collaborating to improve surgical care, significantly cut the rate of surgical infections for more than 35,000 patients in a year-long, nationwide effort sponsored by the federal Centers for Medicare & Medicare ...More
    June 24, 2005 Posted in News
  • Antibiotics Have Little Benefit for Uncomplicated Lower Respiratory Tract Infections
    Patients with uncomplicated lower respiratory tract infections, such as bronchitis, who were given antibiotics had little difference in symptom relief compared to patients who did not receive antibiotics, according to a study in JAMA. Acute lower respiratory tract illness ...More
    June 21, 2005 Posted in News
  • FDA Approves Tygacil, a Novel IV Antibiotic
    MADISON, N.J. -- The Food and Drug Administration (FDA) today approved Tygacil (tigecycline), a novel IV antibiotic with a broad spectrum of antimicrobial activity, including activity against the drug-resistant bacteria methicillin-resistant Staphylococcus aureus ...More
    June 16, 2005 Posted in News
  • Quickly Matching the Drug with the Bug Saves Lives
    University of Florida researchers are resurrecting an old technology to more quickly and accurately identify potentially deadly bacterial infections in hospital patients. Speed in identifying these bugs is crucial because bacteria such as E. coli can enter a patient's ...More
    June 13, 2005 Posted in News
  • Nanotech Method Detects Respiratory Virus
    In what may be one of the first medical uses of nanotechnology, a chemist and a doctor who specializes in infectious childhood diseases have joined forces to create an early detection method for a respiratory virus that is the most common cause of hospitalization among ...More
    June 10, 2005 Posted in News
  • Watch and Wait: A Shift in Approach to Kids' Ear Infections
    The most frequent reason pediatricians prescribe antibiotics to young children is for an ear infection (acute otitis media). With increased concerns about high rates of antibiotic use and resistance, recent guidelines suggest consideration of "watchful waiting" for some ear ...More
    June 6, 2005 Posted in News
  • Nabi Biopharmaceuticals Initiates S. Epidermidis Vaccine Phase I Study
    ROCKVILLE, Md. -- Nabi Biopharmaceuticals announced today the initiation of the first human clinical study of its vaccine being developed to prevent Staphylococcus epidermidis infections in at-risk patients.  At-risk patients include neonates, patients with indwelling ...More
    May 26, 2005 Posted in News